State v. J.D.B. (2026 WI 5): Appellate Review Framework for Sell Orders—Factor One De Novo; Factors Two–Four Clearly Erroneous; Green Checklist Rejected

I. Introduction

Case: State v. J.D.B., 2026 WI 5 (Wis. Feb. 25, 2026).
Parties: State of Wisconsin (Plaintiff-Respondent-Petitioner) v. J.D.B. (Defendant-Appellant).
Posture: The Wisconsin Supreme Court reviewed a published decision of the court of appeals reversing a circuit court order authorizing involuntary administration of antipsychotic medication to restore a criminal defendant’s competency to stand trial.

The defendant (“Jared,” a pseudonym) was charged with battery to a law enforcement officer after an incident precipitated by a mental health crisis. He was found incompetent to proceed and committed for treatment. When he later refused antipsychotic medication and decompensated, the State sought (and obtained) an involuntary-medication order designed to restore competency for trial.

The case presented two recurring, statewide issues in competency-restoration litigation:

  1. Constitutional: How should Wisconsin appellate courts review the four factors required by Sell v. United States, 539 U.S. 166 (2003), when medication is compelled solely to render a defendant competent for trial?
  2. Statutory: Whether the evidentiary record satisfied Wisconsin’s incompetency-to-refuse-treatment findings under WIS. STAT. § 971.14(3)(dm) and (4)(b).

Although the order expired during appeal (mootness), the court reached the merits, invoking the familiar rationale that these short-lived orders often evade review and implicate significant liberty interests (citing, inter alia, State v. Fitzgerald, 2019 WI 69, and Winnebago Cnty. v. C.S., 2020 WI 33).

II. Summary of the Opinion

The Wisconsin Supreme Court (Hagedorn, J.) reversed the court of appeals and reinstated the involuntary medication order. It held:

  • Standard of review (new Wisconsin rule):
    • Sell factor 1 (“important governmental interests are at stake”) is reviewed de novo, with deference to underlying factual findings.
    • Sell factors 2–4 (efficacy/fairness, necessity/alternatives, and medical appropriateness) are predominantly factual determinations reviewed for clear error.
  • Clarification/limitation of prior Wisconsin case law: To the extent State v. Green, 2021 WI App 18, is read as imposing a mandatory “checklist” of evidentiary items (e.g., specific medication, maximum dosages, duration, weight, illness duration, etc.), that reading is rejected; if it required every listed item as mandatory, it is overruled to that extent.
  • Application: The circuit court correctly found all four Sell factors and the statutory requirements under § 971.14(3)(dm) and (4)(b); the findings on factors 2–4 and the statutory elements were not clearly erroneous.

Justice Crawford dissented, concluding that special circumstances—likely civil commitment and extensive pretrial confinement relative to a likely sentence—reduced the State’s prosecutorial interest such that Sell factor 1 was not satisfied.

III. Analysis

A. Precedents Cited

1. Sell v. United States, 539 U.S. 166 (2003)

Sell is the constitutional source of the four-factor test governing involuntary medication to restore competency for trial. The Wisconsin Supreme Court treated Sell as establishing both: (i) the defendant’s due-process liberty interest against unwanted antipsychotic medication, and (ii) the limited circumstances when the State’s trial-related interest can override it.

The court’s most consequential move was to operationalize Sell for appellate review: it characterized factor 1 as a legal “threshold” question (importance of the governmental interest), and factors 2–4 as medical and evidentiary determinations committed to the circuit court as factfinder.

2. Washington v. Harper, 494 U.S. 210 (1990)

Harper supplied the foundational proposition that the Due Process Clause protects a “significant liberty interest” in avoiding unwanted antipsychotic medication. In J.D.B., Harper frames why a heightened, structured constitutional inquiry is required before compelling medication.

3. State v. Fitzgerald, 2019 WI 69, 387 Wis. 2d 384, 929 N.W.2d 165

Fitzgerald held Wisconsin’s competency-restoration involuntary-medication statutes are unconstitutional to the extent they compel medication without the findings required by Sell. J.D.B. builds on Fitzgerald not by altering the substantive Sell obligations, but by clarifying how appellate courts review those findings and how much specificity Sell demands from the State’s proof.

4. State v. Green, 2021 WI App 18, 396 Wis. 2d 658, 957 N.W.2d 583

Green was a pivotal comparator because it reversed an involuntary-medication order where the record was generic and untethered to the defendant: limited contact with the defendant, no meaningful medical-history review, and a non-tailored plan. The J.D.B. court endorsed Green’s core principle—the State must present an individualized treatment plan—but rejected any interpretation turning Green’s discussion into a mandatory checklist of evidentiary items.

This is a major doctrinal refinement: Wisconsin now requires individualized proof, but allows flexibility in how the State demonstrates it, so long as the circuit court can make the Sell findings on an adequate record.

5. Federal appellate decisions on standards of review (as cited in the opinion)

The majority emphasized national consensus, citing a long list of federal cases for the proposition that Sell factor 1 is reviewed as a legal question, while factors 2–4 are reviewed for clear error as factual findings. The opinion lists, among others: United States v. Gomes, United States v. Grape, United States v. Evans, United States v. Palmer, United States v. Green, United States v. Fieste, United States v. Fazio, United States v. Hernandez-Vasquez, United States v. Bradley, United States v. Diaz, and United States v. Dillon.

Those cases functioned less as substantive constitutional authorities and more as comparative institutional guidance: they supported the Wisconsin court’s allocation of decision-making responsibility between trial and appellate courts.

6. Standards-of-review and institutional-competence authorities

To justify the split standard of review, the court relied on authorities explaining why appellate courts defer to trial courts on factfinding: Utah v. Thurman, 846 P.2d 1256 (Utah 1993) (standards allocate power), Ronald R. Hofer’s article (Standards of Review-Looking Beyond the Labels), State v. Owens, 148 Wis. 2d 922 (1989) (trial court superior vantage on testimony), and Wisconsin cases applying clear error vs de novo review such as State v. Burch, 2021 WI 68, and Serv. Emps. Int'l Union Healthcare v. WERC, 2025 WI 29.

The court also referenced State v. Byrge, 2000 WI 101, for the proposition that whether something is fact or law is itself a legal question.

7. “Special circumstances” and related reasoning

In applying factor 1, the court rejected several asserted mitigators:

  • A potential insanity defense does not reduce the State’s interest because it is “logically backwards” to use a possible defense to justify foregoing prosecution; the court cited United States v. Mikulich, 732 F.3d 692 (6th Cir. 2013).
  • Alleged bail/pretrial detention errors were deemed insufficiently connected to the prosecutorial-interest calculus as presented.
  • Delayed treatment, without a developed nexus to the prosecution interest, did not reduce the State’s interest in bringing charges to adjudication.
  • The possibility of future civil commitment had limited mitigating force on this record because, at the time of the circuit court decision, a ch. 51 proceeding had not begun and long-term commitment was uncertain.

8. Statutory evidentiary burden and Outagamie County v. Melanie L, 2013 WI 67, 349 Wis. 2d 148, 833 N.W.2d 607

On the statutory incompetency-to-refuse-medication findings, the defendant relied on language in Outagamie County v. Melanie L. The majority treated Melanie L as not adding mandatory evidentiary requirements beyond the statute’s text. The court emphasized that § 971.14(3)(dm) requires: (1) explanation of advantages/disadvantages/alternatives, and (2) incapacity to express or apply understanding—and that the circuit court’s findings were supported by testimony that the physician held multiple conversations about medications and side effects and concluded the defendant could not apply the information to himself.

B. Legal Reasoning

1. The central doctrinal move: a bifurcated appellate standard of review

The majority framed the four Sell factors as serving different functions. Factor 1 is an evaluative, normative judgment about whether prosecution interests are sufficiently weighty to override liberty interests. That question, though informed by facts (seriousness of crime, confinement time, etc.), is predominantly legal in character and benefits from statewide uniformity—hence de novo review.

By contrast, factors 2–4 require the circuit court to evaluate medical evidence: likelihood of restoration, side effects and trial fairness, necessity relative to alternatives, and whether medication is in the patient’s best medical interest. These are credibility- and expert-driven determinations for which the circuit court is institutionally better suited. Accordingly, the Supreme Court adopted clear-error review for factors 2–4.

2. Recalibrating Wisconsin’s evidentiary expectations after Green

The opinion walks a careful line:

  • Required: an individualized treatment plan and individualized findings supporting the Sell factors.
  • Not required: a rigid, mandatory inventory of each data point listed in Green (if Green was read that way).

This matters because it shifts litigation from “did the State check every box?” to “does the record permit individualized findings meeting the Sell standards?”

3. Application of factor 1 (important governmental interest)

The court accepted as undisputed that felony battery to a law enforcement officer is “serious,” and it declined to announce a broader seriousness framework. It then tested claimed “special circumstances” and found none eliminated the State’s interest, though pretrial confinement had some mitigating effect.

Notably, the court treated “special circumstances” as exceptional and case-specific, not a second prong with fixed elements. The analysis focuses on whether mitigation is strong enough to make the interest no longer “important,” not whether a circumstance can be labeled “special.”

4. Application of factors 2–4 under clear-error review

The court emphasized record support for individualized medical judgment: the physician reviewed records, met with the defendant multiple times, discussed side effects and benefits, explained titration and starting doses, and testified (without contest) that medication would reduce psychosis symptoms, improve competency, and was medically appropriate. Conflicts or alternative inferences were deemed insufficient to overturn the circuit court’s findings given the deferential standard (citing State v. Wiskerchen, 2019 WI 1).

5. Statutory requirements under WIS. STAT. § 971.14(3)(dm)

The court reaffirmed that the statute requires proof of explanation plus incapacity to express or apply understanding. It held the circuit court’s findings were supported where the physician testified to two separate explanatory meetings and to the defendant’s repeated, non-engaging response (“he doesn’t need” medication), supporting the conclusion that he could not apply the information to himself.

The majority criticized the court of appeals for effectively reweighing testimony rather than applying clear-error deference.

6. The dissent’s contrasting approach

Justice Crawford agreed the first factor is reviewed de novo but disagreed on the outcome: she would find factor 1 not met because the State’s interest was significantly reduced by (i) likely civil commitment and (ii) eight months of pretrial custody trending toward a “time served” disposition given the defendant’s youth, lack of record, and disabilities (invoking general sentencing principles and citing State v. Gallion, 2004 WI 42). The dissent also stressed the intrusive nature of forced medication (quoting Washington v. Harper).

C. Impact

1. Clear statewide guidance on appellate review in forced-medication-to-restore-competency cases

J.D.B. establishes a durable procedural framework for Wisconsin: factor 1 is reviewed independently; factors 2–4 are insulated by clear-error deference. Practically, this will make appellate reversals more likely to occur at factor 1 (importance of prosecution interest) than on medical-evidence disputes, absent demonstrable evidentiary gaps or internally inconsistent findings.

2. Narrowing and clarifying Green

By rejecting a rigid checklist reading of State v. Green, the court reduces the risk that constitutionality turns on formalistic omissions rather than the substance of individualized medical proof. At the same time, J.D.B. preserves Green’s essential warning: generic, non-individualized plans remain inadequate.

3. Litigation behavior and record development

The opinion signals to litigants that:

  • Defendants should develop “special circumstances” in the circuit court; the majority noted forfeiture principles discussed in United States v. Dillon and United States v. Fieste, even though it did not resolve forfeiture here.
  • The State should build a record supporting individualized findings, but it is not necessarily required to present every data point listed in Green if the testimony and plan permit the circuit court to make the Sell findings.

4. Substantive balancing under factor 1 remains contestable

While the court declined to build a seriousness framework, the dissent illustrates likely future battlegrounds: the weight given to time served, anticipated sentence length, and foreseeability of civil commitment in determining whether the prosecutorial interest remains “important.”

IV. Complex Concepts Simplified

  • Competency to stand trial: A defendant must understand the proceedings and be able to assist counsel. If not, criminal proceedings pause while the State attempts restoration.
  • Involuntary medication for restoration (a “Sell order”): A court order allowing forced administration of antipsychotic drugs solely to make a defendant competent for trial, subject to four constitutional findings.
  • The four Sell factors (in plain terms):
    1. Importance: Is prosecution important enough here to override bodily autonomy?
    2. Efficacy & fairness: Will meds likely restore competency, without side effects that make trial unfair?
    3. Necessity: Are there less intrusive ways (or alternatives) that would work?
    4. Medical appropriateness: Is this in the patient’s best medical interest?
  • De novo review: The appellate court decides the issue fresh, owing no deference on the ultimate legal conclusion (while still accepting supported factual findings).
  • Clearly erroneous: A high-deference standard; if the record permits a reasonable factfinder to reach the circuit court’s finding, the appellate court must affirm even if it might have weighed the evidence differently.
  • Individualized treatment plan: A plan tailored to the defendant’s condition and history, not a generic template; required, but not necessarily in a rigid checklist format.
  • Mootness (and why the court still decided the case): Even though the order expired, the court addressed the merits because these orders are time-limited, implicate significant liberty interests, and often evade timely review.

V. Conclusion

State v. J.D.B. reshapes Wisconsin’s forced-medication jurisprudence primarily by establishing a clear appellate-review regime for Sell findings: factor 1 is reviewed de novo, while factors 2–4 are factual findings reviewed for clear error. The decision also rejects a mandatory-checklist reading of State v. Green, reaffirming that Sell requires individualized proof but not rigid formalism.

The broader significance is institutional: circuit courts become the principal adjudicators of the medical and treatment details, and appellate courts will intervene chiefly where the State’s prosecutorial interest is not sufficiently important (or where medical findings lack record support). The dissent underscores that factor 1’s “special circumstances” balancing—especially involving time served and likely civil commitment—will remain the most contested terrain in future cases.